A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity

Blood

Volumn 99, Issue 7, 2002, Pages 2434-2441

  Brooks, Marjory B ^a,b   Catalfamo, James L ^a,b   Brown, H Alex ^b   Ivanova, Pavlina ^a,b   Lovaglio, Jamie ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM IONOPHORE; COLLAGEN; PHOSPHATIDYLSERINE; PHOSPHOLIPID; THROMBIN; THROMBOCYTE FACTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLEEDING DISORDER; BLEEDING TIME; BLOOD CLOT RETRACTION; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CALCIUM MOBILIZATION; CELL LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MODEL; DOG; EPISTAXIS; FEMALE; FLOW CYTOMETRY; GENETIC DISORDER; HEMATOMA; HOMOZYGOTE; HYPHEMA; MALE; MEMBRANE VESICLE; NONHUMAN; PEDIGREE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SCOTT SYNDROME; SIGN TEST; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE RELEASE REACTION;

EID: 0036530015     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2434     Document Type: Article

References (55)

1. Changes in membrane phospholipid distribution during platelet activation
2. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis
3. Surface-dependent hemostasis
4. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
5. Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes
6. Lipid translocation across the plasma membrane of mammalian cells
7. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes
8. Transbilayer movement of phospholipids in red cell and platelet membranes
9. Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid
10. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids
11. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: A study using Ca2+-ATPase inhibitors
12. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
13. Procoagulant expression in platelets and defects leading to clinical disorders
14. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen
15. Thrombin receptor activating peptide does not stimulate platelet procoagulant activity
16. Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets
17. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity
18. Fibrin-dependent platelet procoagulant activity requires GP1b receptors and von Willebrand factor
19. Scott syndrome: A disorder of platelet coagulant activity
20. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity - A comparison with Scott syndrome
21. The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca(2+)-induced loss of phospholipid asymmetry in the human erythrocyte: A study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling
22. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: A study using physiologic agonists and local anaesthetics
23. Isolated deficiency of platelet procoagulant activity
24. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder
25. Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells
26. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome
27. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
28. Activated coagulation time (ACT) of whole blood in normal dogs
29. A sensitive immunoassay for von Willebrand factor
30. Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies
31. Von Willebrand disease phenotype and von Willebrand factor marker genotype in Doberman Pinschers
32. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs
33. Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders
34. Defective platelet-fibrinogen interaction in hereditary canine thrombopathia
35. Chrono-lume and magnesium potentiate aggregation of canine but not human platelets in citrated platelet-rich plasma
36. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation
37. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles
38. A rapid method of total lipid extraction and purification
39. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups
40. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity
41. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin
42. The Xylum Clot Signature Analyzer: A dynamic flow system that simulates vascular injury
43. Effects of diets high in saturated fat and cholesterol on the lipid composition of canine platelets
44. A review of canine inherited bleeding disorders: Biochemical and molecular strategies for disease characterization and carrier detection
45. Insights from von Willebrand disease animal models
46. Thrombopathias
47. A 2H-NMR study on the interactions of the local anesthetic tetracaine with membranes containing phosphatidylserine
48. Application of light-scattering theory to the optical effects associated with the morphology of blood platelets
49. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets
50. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin
51. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: Evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses
52. Comparison between the loss of platelet membrane asymmetry, microvesiculation and the tyrosine phosphorylation of proteins
53. Receptors and signalling mechanisms in the procoagulant response of platelets
54. Significance of capacitative Ca2+ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells
55. Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: A study using an inhibitor for scramblase that mimics the defect in Scott syndrome